Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Dow Jumps 250 Points; Crude Oil Rises Over 1%
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday.
Akari Therapeutics Announced 15M ADS Registered Direct Offering Priced @$0.85/ADS
Akari Therapeutics, Plc (Nasdaq: AKTX) today announced it has entered into definitive agreements with healthcare-focused institutional investors alongside participation from certain existing investors, including the Akari Executive Chairman of the Board of Directors, Dr.
Akari Therapeutics To Reallocate Cash And Resources To Phase 3 Trial On Nomacopan In HSCT-TMA And To Pre-Clinical Program Of PAS-Nomacopan In GA; Will Discontinue Clinical Program Evaluating Nomacopan In Bullous Pemphigoid, Says Is Not Reducing Headcou…
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that it is prioritizing two pipeline programs. Cash and
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million.
Akari Therapeutics Presents Results From The CASCADE And CORONET Studies In COVID-19 At The American Thoracic Society 2022 Annual Meeting
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, presented results from the CASCADE and CORONET studies in